QC
BNGO icon

Quadrature Capital’s Bionano Genomics BNGO Stock Holding History

Quadrature Capital’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,472
Closed -$97.2K – 1147
2024
Q1 		$97.2K Sell
1,472
-382
-21% -$28.5K ﹤0.01% 1133
2023
Q4 		$209K Buy
+1,854
New +$194K ﹤0.01% 975
2023
Q2 		– Sell
-284
Closed -$187K – 1006
2023
Q1 		$187K Buy
+284
New +$252K 0.01% 780

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Quadrature Capital's BNGO Position: Q2 2024 in Review

Quadrature Capital sold out of Bionano Genomics (BNGO) in Q2 2024, closing a stake of 1,472 shares — an estimated $97.2K sold.

Quadrature Capital first reported a position in BNGO in Q1 2023 and held it in 3 quarters. The position peaked at $209K in Q4 2023. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

  • Quadrature Capital reported no remaining Bionano Genomics position as of Q2 2024 after selling out during the quarter.
  • Quadrature Capital sold 1,472 Bionano Genomics shares in Q2 2024, an estimated $97.2K.
  • Quadrature Capital first reported a position in Bionano Genomics in Q1 2023 and held it in 3 quarters.
  • Quadrature Capital's Bionano Genomics position peaked at $209K in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on Quadrature Capital's 13F filing for Q2 2024, filed 14 Aug 2024.